IVZ Stock Analysis: Buy, Sell, or Hold?
IVZ - Invesco LTD
$27.18
-1.61 (-5.58%)
▼
5d:
-6.62%
30d:
+0.72%
90d:
+14.32%
HOLD
LOW Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Jul 28, 2026
Smart Money Accumulation
None View Scanner →
Strength: 6.2/10
Get Alerted When IVZ Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IVZ is fairly valued with market pricing in 1.7% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: IVZ is fairly valued with market pricing in 1.7% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$43.14
Based on 9.6% avg growth
INTRINSIC VALUE TODAY
$26.79
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IVZ is currently trading at $27.18, which is considered slightly low relative to its 30-day fair value range of $27.08 to $28.53. The stock's valuation (Forward PE: 9.7) is in line with its historical norms (9.2). At these levels, the market is pricing in 1.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, IVZ is in a strong uptrend. The price is currently testing key support at $26.72. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.6% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IVZ is in a strong uptrend. The price is currently testing key support at $26.72. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.6% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$27.08 -
$28.53
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
71.0%
Protect Your Profits
Holding IVZ? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.6%)
- NEUTRAL: Near Wall St target ($29.68)
- NEUTRAL: Market pricing in 1.7% annual earnings growth - fairly valued
- CAUTION: Recommendation downgraded due to -6.6% 5-day decline
Trading Range Analysis
30-Day Trading Range
$27.08 -
$28.53
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$26.72
Resistance Level
$28.71
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.65
Wall Street Target
$29.68
(+3.1%)
Revenue Growth (YoY)
14.1%
Earnings Growth (YoY)
35.0%
Profit Margin
-3.7%
Valuation Premium vs History
+1.7% premium
PE vs Historical
9.7 vs 9.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.7%
(market-implied from PE analysis)
1-Year Target
$29.27
(+2%)
2-Year Target
$29.77
(+3%)
3-Year Target
$30.27
(+5%)
3-Yr Target (if PE normalizes)
(PE: 10→9)
PE COMPRESSION
$28.85
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 15.1%)
$99.02
(+244%)
Base:
(SPY PE: 9.7, Growth: 15.1%)
$43.89
(+53%)
Bear:
(PE: 8.2, Growth: 15.1%)
$37.31
(+30%)
Share & Embed Analysis
Last updated: June 23, 2026 1:39 PM ET
Data refreshes hourly during market hours. Next update: 2:39 PM
Data refreshes hourly during market hours. Next update: 2:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IVZ showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin Hern
SELL
2026-03-17
Gilbert Ray Cisneros, Jr.
SELL
2026-02-10
Gilbert Ray Cisneros, Jr.
BUY
2026-01-09
Top Rated Asset Management Stocks
Top-rated stocks in Asset Management by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BLK
BlackRock Inc |
STRONG BUY
17 analysts |
$1246 | 59 HOLD |
|
HASI
Hannon Armstrong Sustain… |
STRONG BUY
16 analysts |
$49 | 63 BUY |
|
BX
Blackstone Group Inc |
HOLD
23 analysts |
$143 | 58 HOLD |
|
OWL
Blue Owl Capital Inc |
STRONG BUY
15 analysts |
$13 | 56 HOLD |
|
CRBG
Corebridge Financial Inc. |
STRONG BUY
14 analysts |
$35 | 61 BUY |
Advanced IVZ Option Strategies
Professional options setups generated by AI based on today's IVZ price and gamma walls.
